SCOTUS' Mifepristone Decision Sets High Bar For US FDA Suits

Agency Authority Still Faces Risks

 
• By Sarah Karlin-Smith
  
female athlete performing high jump
The US Supreme Court abortion pill opinion sets a high bar for FDA lawsuits, but future tests of FDA's authority remain a risk. • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Legal & IP

More from Business